Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Category 1 vs. Category 2. The FDA's peptide update, explained. Category 2 peptides are on the FDA's difficult to compound list, which effectively blocks licensed pharmacies from producing them. Category 1 means An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica